Pharmacological characterization of α 2-adrenoceptor-mediated responses in pig nasal mucosa

Autonomic and Autacoid Pharmacology

Volumn 23, Issue 4, 2003, Pages 208-219

  Corboz, M R ^a   Varty, L M ^a   Rizzo, C A ^a   Mutter, J C ^a   Rivelli, M A ^a   Wan, Y ^a   Umland, S ^a   Qiu, H ^a   Jakway, J ^a   McCormick, K D ^a   Berlin, M ^a   Hey, J A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

2 adrenoceptor subtypes; BHT 920; Oxymetazoline; Phenylephrine; Pig nasal mucosa; UK 14,304

Indexed keywords

(4,5 DIHYDRO 1H IMIDAZOL 2 YL)(4 METHYL 1H BENZOIMIDAZOL 5 YL)AMINE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ETHYL 3,4,5 TRIMETHOXY ALPHA [3 [[2 (2 METHOXYPHENOXY)ETHYL]AMINO]PROPYL]BENZENEACETONITRILE FUMARATE; BRIMONIDINE; OXYMETAZOLINE; PGE 6201204; PHENYLEPHRINE; PRAZOSIN; RAUWOLSCINE; RECEPTOR SUBTYPE; SPIROXATRINE; TALIPEXOLE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; MALE; NONHUMAN; NOSE MUCOSA; SWINE; VASOCONSTRICTION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; NASAL MUCOSA; PROTEIN BINDING; RECEPTORS, ADRENERGIC, ALPHA-2; SWINE;

EID: 2342577385     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2003.00298.x     Document Type: Article

References (59)

1. ANDERSSON, K.-E. & BENDE, M. (1984). Adrenoceptors in the control of human nasal mucosa blood flow. Ann. Otol. Rhinol. Laryng., 93, 179-182.
2. ANGGARD, A. & EDWALL, L. (1974). The effects of sympathetic nerve stimulation on the tracer disappearance rate and local blood content in the nasal mucosa of the cat. Acta Otolaryngol., 77, 131-139.
3. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-58.
4. BERRIDGE, T.L. & ROACH, A.G. (1986). Characterization of the α-adrenoceptors in the vasculature of the canine nasal mucosa. Br. J. Pharmacol., 88, 345-354.
5. BYLUND, D.B., EIKENBURG, D.C., HIEBLE, J.P., LANGER, S.Z., LEFKOWITZ, R.J., MINNEMAN, K.P., MOLINOFF, P.B., RUFFOLO, R.R. & TRENDELENBURG, U. (1994). International Union of Pharmacology nomenclature on adrenoceptors. Pharmacol. Rev., 46, 121-136.
6. CAUNA, N. (1982). Blood and nerve supply of the nasal lining. In: The Nose: Upper Airway Physiology and the Atmospheric Environment, Chapter 4 (Eds D.F. PROCTOR & I.B. ANDERSON), pp. 45-69. Elsevier, Amsterdam.
7. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
8. 2A/D-adrenoceptor knockout mice. Br. J. Pharmacol., 136, 857-864.
9. COTTON, C.U., STUTTS, M.J., KNOWLES, M.R., GATZY, J.T. & BOUCHER, R.C. (1987). Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. J. Clin. Invest., 79, 80-85.
10. DAHLSTROM, A. & FUXE, K. (1965). The adrenergic innervation of the nasal mucosa of certain animals. Acta Otorhinolaryngol., 59, 65-72.
11. 3H]RX821002 binding and definition of additional selective drugs. Eur. J. Pharmacol., 252, 43-49.
12. DRUCE, H.M., BONNER, R.F., PATOW, C., CHOO, P., SUMMERS, R.J. & KALINER, M.A. (1984). Response of nasal blood flow to neurohormones as measured by laser-Doppler velocimetry. J. Appl. Physiol., 57, 1276-1283.
13. ECCLES, R. (1982). Neurological and pharmacological considerations. In: The Nose: Upper Airway Physiology and the Atmospheric Environment, Chapter 8 (Eds D.F. PROCTOR & I.B. ANDERSON), pp. 191-214. Elsevier, Amsterdam.
14. ECCLES, R. & ECCLES, K.S.J. (1981). Sympathetic innervation of the nasal mucosa of the pig. Res. Vet. Sci., 30, 349-352.
15. EMPEY, D.W. & MEDDER, K.T. (1981). Nasal decongestants. Drugs, 21, 438-443.
16. FRANKE, F.E. (1966). Sympathetic control of the dog's nasal blood vessels. Proc. Soc. Exp. Biol. Med., 57, 1276-1283.
17. 2C-Adrenoceptors mediate contractile responses to noradrenaline in the human saphenous vein. Naunyn Schmiedebergs Arch. Pharmacol., 355, 406-411.
18. 2a-autoreceptors in the human gastric and ileocolic arteries. Naunyn Schmiedebergs Arch. Pharmacol., 358, 207-211.
19. 2-adrenergic receptor. J. Biol. Chem., 265, 17307-17317.
20. HARE, W.C.D. (1975). General respiratory system. In: The Anatomy of the Domestic Animals (Eds S. SISSON & J.D. GROSSMAN), pp. 113-144. W.B. Saunders, Philadelphia, PA.
21. 1- and α2-adrenoceptors. Prog. Drug Res., 47, 81-130.
22. 2-adrenoceptors in blood vessels of human nasal mucosa. Arch. Otolaryngol., 245, 127-131.
23. 2-adrenoceptors in the nasal blood vessels of the dog. Arch. Otolaryngol., 110, 647-651.
24. JACKSON, R.T. (1979). A new in vitro method of drug assay of nasal blood vessels. Arch. Otorhinolaryngol., 225, 33-38.
25. JACKSON, R.T. (1982). Evidence for presynaptic parasympathetic receptors on nasal blood vessels. Ann. Otol. Rhinol. Laryngol., 91, 216-219.
26. 1-Receptors at pre-capillary resistance vessels of the human nasal mucosa. Rhinology, 35, 161-165.
27. KORHONEN, L.K., HOLOPAINEN, E. & PAAVOLAINEN, M. (1969). Some histochemical characteristics of tracheobronchial tree and pulmonary neoplasms. Acta Histochem. Bd., 32, S57-S73.
28. LACROIX, J.S. (1989). Adrenergic and non-adrenergic mechanisms in the sympathetic vascular control of the nasal mucosa. Acta Physiol. Scand., 136 (Suppl. 582), 1-63.
29. LACROIX, J.S. & LUNDBERG, J.M. (1989). Sympathetic vascular control of the pig nasal mucosa: adrenoceptor mechanisms in blood flow and volume control. Br. J. Pharmacol., 97, 1075-1084.
30. LACROIX, J.S., STJARNE, P., ANGGARD, A. & LUNDBERG, J.M. (1988). Sympathetic vascular control of the pig nasal mucosa: (I) increased resistance and capacitance vessel responses upon stimulation with irregular bursts compared to continuous impulses. Acta Physiol. Scand., 132, 83-90.
31. 1A-adrenergic receptor (The gene for which is located on human chromosome 5). J. Biol. Chem., 266, 6365-6369.
32. MACIA, R.A., MATTHEWS, W.D., LAFFERTY, J. & DEMARINIS, R.M. (1984). Assessment of alpha-adrenergic receptor subtypes in isolated rat aortic segments. Naunyn Schmiedebergs Arch. Pharmacol., 325, 306-309.
33. MACKINNON, A.C., SPEDDING, M. & BROWN, C.M. (1994). Alpha2-adrenoceptors: more subtypes but fewer functional differences. Trends Pharmacol. Sci., 15, 119-123.
34. 2A subtype. Br. J. Pharmacol., 121, 1721-1729.
35. MALM, L. (1974). Responses of resistance and capacitance vessels in feline mucosa to vasoactive agents. Acta Otorhinolaryngol., 78, 90-97.
36. MUJIC, M. & VAN ROSSUM, J.M. (1965). Comparative pharmacodynamics of sympathomimetic imidazolines; studies on intestinal smooth muscle of the rabbit and the cardiovascular system of the cat. Arch. Int. Pharmacodyn., 155, 432-449.
37. O'DONNELL, S.R. (1995). Sympathomimetic vasoconstrictors as nasal decongestants. Med. J. Aust., 162, 264-267.
38. 2-adrenoceptor subtypes in dog and rat veins. Br. J. Pharmacol., 127, 5P.
39. 2C-adrenoceptors in human neuroblastoma SH-SY5Y cells. Eur. J. Pharmacol., 372, 109-115.
40. α protein stoichiometry. Naunyn Schmiedebergs Arch. Pharmacol., 363, 526-536.
41. PHILLIPS, J.E., HEY, J.A. & CORBOZ, M.R. (2002). Effects of ion transport inhibitors on MCh-mediated secretion from porcine airway submucosal glands. J. Appl. Physiol., 93, 873-881.
42. POUND, W.J. & HOUPT, K.A. (1978). The pig as a model in biomedical research. In: The Biology of the Pig (Ed. W.G. POND), pp. 13-64. Comstock Publishing Associates, Cornell University Press, Ithaca, NY.
43. 2c-adrenoceptor contractility in human saphenous vein. Eur. J. Pharmacol., 413, 263-269.
44. ROOKER, D.W. & JACKSON, R.T. (1969). The effects of certain drugs, cervical sympathetic stimulation and section on nasal patency. Ann. Otol. Rhinol. Laryngol., 78, 403-414.
45. 2 adrenergic agonist. FASEB J., 10, A426.
46. 2-adrenoceptor mediating contractions of the human saphenous vein. Br. J. Pharmacol., 106, 447-451.
47. STEEN, S., SJÖBERG, T., SKÄRBY, T., NORGREN, L. & ANDERSSON, K.-E. (1984). The postjunctional α-adrenoceptors of the human saphenous vein. Acta Pharmacol. Toxicol., 55, 351-357.
48. TALLARIDA, R.J. (1988). I. Pharmacologic methods for identification of receptors. Life Sci., 43, 2169-2176.
49. TALLARIDA, R.J. & MURRAY, R.B. (1981). Manual of Pharmacologic Calculations with Computer Programs. Springer-Verlag, New York.
50. 2-autoreceptors: rat vena cava, rat atria, human kidney and guinea pig urethra. Naunyn Schmiedebergs Arch. Pharmacol., 356, 721-737.
51. 3H]-MK912 is alpha-2c selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors. J. Pharmacol. Exp. Ther., 271, 1558-1565.
52. 3H]MK912 and subtype-selective drugs. Brain Res., 770, 261-266.
53. 2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine. Eur. J. Pharmacol., 343, 93-101.
54. 35S]GTPγS and cAMP functional assays. Eur. J. Pharmacol., 411, 211-221.
55. WADELL, C., BJORK, E. & CAMBER, O. (1999). Nasal drug delivery - evaluation of an in vitro model using porcine nasal mucosa. Eur. J. Pharm. Sci., 7, 197-206.
56. WEINSTEIN, J.S., GROSSMAN, W., WEINTRAUB, R.M., THURER, R.L., JOHNSON, R.G. & MORGAN, K.G. (1989). Differences in α-adrenergic responsiveness between human internal mammary arteries and saphenous veins. Circulation, 79, 1264-1270.
57. 2A-adrenoceptor-mediated vasoconstriction by brominidine in porcine ciliary arteries. Invest. Ophthalmol. Vis. Sci., 42, 2049-2055.
58. 2C-adrenoceptors in the pig cerebellum and kidney cortex. Eur. J. Pharmacol., 284, 271-279.
59. WILSON, H. & YATES, M.S. (1978). Bilateral nasal vascular responses to unilateral sympathetic stimulation. Acta Otolaryngol., 85, 105-110.